Flanders Vaccine Pitch & Match Session

13 Jun 2024 | Park Inn by Radisson Leuven

Sven ARNOUTS

Business Development Manager

Ghent University - PROVAXS

Merelbeke, Please select, Belgium

3 profile visits

Passionate about innovations in animal health and translational medicine

My organisation

Ghent University - PROVAXS

Ghent University - PROVAXS

Academic institution

Merelbeke, Belgium

Provaxs is Ghent University’s Business Development Center and industrial liaison for innovation in animal health. We combine scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals. Not only that, but thanks to the Industrial Research Fund of Ghent University we have access to proof-of-concept funding, open for collaboration with industry. We are receptive to all types of collaborations and partnerships:  out-licensing and development of our UGent-technologies towards the final product, research collaboration on a single project, either bilateral or in a research consortium, strategic partnerships with a specific focus/topic.  All our collaborations and partnerships are supported by a professional business development/tech-transfer team and are based on solid tailor-made agreements on confidentiality, ownership, and exploitation of results.
Read more

About me

As Business Developer Dr. Sven Arnouts coordinates technology transfer for PROVAXS at Ghent University in Belgium.

He facilitates interaction and collaboration between industry and Ghent University's experts in infectious diseases and immunity in animal health.  In 2019 he started the One Health Platform at Ghent University.

Dr. Arnouts graduated in 1990 as Bio-engineer in animal breeding and cell and gene technology.  In 1994 he obtained his PhD in avian growth physiology and immunology at the University of Leuven on an industrial project in collaboration with Solvay-Duphar.  From 1994 to 2006 he was global R&D Manager Agriculture at INVE where he was responsible for research activities in animal nutrition for pigs, poultry and ruminants with a special focus on the relation between nutrition and health.

Dr. Arnouts

  • is Chairman of the Board of Directors of Flanders Vaccine since January 2016

  • represents Belgium in the Executive Committee of the International Research Consortium STAR-IDAZ IRC

My organisation

Ghent University - PROVAXS

https://www.provaxs.com

Provaxs is Ghent University’s Business Development Center and industrial liaison for innovation in animal health.

We combine scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals. Not only that, but thanks to the Industrial Research Fund of Ghent University we have access to proof-of-concept funding, open for collaboration with industry.

We are receptive to all types of collaborations and partnerships:

  •  out-licensing and development of our UGent-technologies towards the final product

  • research collaboration on a single project, either bilateral or in a research consortium

  • strategic partnerships with a specific focus/topic.

 All our collaborations and partnerships are supported by a professional business development/tech-transfer team and are based on solid tailor-made agreements on confidentiality, ownership, and exploitation of results.

Social media

Skills

  • Technology transfer
  • Business Development
  • animal health and welfare

Interests

  • R&D collaboration
  • licensing
  • valorisation
  • one health collaborations

Additional questions

How would you categorise yourself?

Business Developer

Organisation Type

Public / Non-Profit Organisation Academic institution

Areas of expertise

Investment and business developmentIntellectual property Research and developmentVaccine platforms Vaccine delivery systems

Therapeutic areas

Infectious diseases ImmunologyOther